Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ayako Kira
Significant Association Between Low Baseline Neutrophil-To-Lymphocyte Ratio and Improved Progression-Free Survival of Patients With Locally Advanced or Metastatic Breast Cancers Treated With Eribulin but Not With Nab-Paclitaxel
Clinical Breast Cancer
Cancer Research
Oncology
Related publications
Baseline Neutrophil-To-Lymphocyte Ratio (NLR) and Derived NLR Could Predict Overall Survival in Patients With Advanced Melanoma Treated With Nivolumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The Prognostic Impact of Neutrophil-To-Lymphocyte Ratio, Lymphocyte-To-Monocyte Ratio, and Platelet-To-Lymphocyte Ratio in Patients With Advanced Colorectal Cancer Treated With First-Line Chemotherapy
Przeglad Gastroenterologiczny
Gastroenterology
Improved Survival in Patients With Locally Advanced Prostate Cancer Treated With Radiotherapy and Goserelin
New England Journal of Medicine
Medicine
Post-Progression Survival and Progression-Free Survival in Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
Hepatology Research
Hepatology
Infectious Diseases
Association of MDM2 Expression With Shorter Progression-Free Survival and Overall Survival in Patients With Advanced Pancreatic Cancer Treated With Gemcitabine-Based Chemotherapy
PLoS ONE
Multidisciplinary
Quality-Adjusted Survival With Nab -Paclitaxel vs Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
Clinical Breast Cancer
Cancer Research
Oncology
Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression With Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Derived Neutrophil to Lymphocyte Ratio and Monocyte to Lymphocyte Ratio May Be Better Biomarkers for Predicting Overall Survival of Patients With Advanced Gastric Cancer
OncoTargets and Therapy
Oncology
Pharmacology